Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Buser

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host diseaseNathan Cantoni, Hans H Hirsch, Nina Khanna, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitalsManuela Voegtlin, Stephan R Vavricka, Alain M Schoepfer, et al.
Transfusion|June 25, 2010
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic regionMartin Stolz, Caroline Tinguely, Mauro Graziani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012Thomas Volken, Andreas Bänziger, Andreas Buser, et al.
Haematologica|December 2, 2017
In response to the comment by Hechler <i>et al</i>.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
Blood|June 21, 2007
Role of primacy of birth in HLA-identical sibling transplantationChristoph Bucher, Martin Stern, Andreas Buser, et al.
Haematologica|July 22, 2017
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
Blood Transfusion = Trasfusione Del Sangue|October 11, 2016
Red blood cell use in Switzerland: trends and demographic challengesThomas Volken, Andreas Buser, Damiano Castelli, et al.
Blood|January 29, 2008
Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysisAlicia Rovó, Thomas Daikeler, Martin Stern, et al.
Cytotherapy|January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow TransplantationAndreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host diseaseNathan Cantoni, Hans H Hirsch, Nina Khanna, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitalsManuela Voegtlin, Stephan R Vavricka, Alain M Schoepfer, et al.
Transfusion|June 25, 2010
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic regionMartin Stolz, Caroline Tinguely, Mauro Graziani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|December 21, 2016
Too Many Blood Donors - Response Bias in the Swiss Health Survey 2012Thomas Volken, Andreas Bänziger, Andreas Buser, et al.
Haematologica|December 2, 2017
In response to the comment by Hechler <i>et al</i>.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
Blood|June 21, 2007
Role of primacy of birth in HLA-identical sibling transplantationChristoph Bucher, Martin Stern, Andreas Buser, et al.
Haematologica|July 22, 2017
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearanceSimona Stivala, Sara Gobbato, Laura Infanti, et al.
Blood Transfusion = Trasfusione Del Sangue|October 11, 2016
Red blood cell use in Switzerland: trends and demographic challengesThomas Volken, Andreas Buser, Damiano Castelli, et al.
Blood|January 29, 2008
Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysisAlicia Rovó, Thomas Daikeler, Martin Stern, et al.
Cytotherapy|January 21, 2018
Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow TransplantationAndreas Holbro, Helen Baldomero, Francesco Lanza, et al.
Pageof 15